These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 23856888)

  • 21. MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas.
    Saitou M; Goto M; Horinouchi M; Tamada S; Nagata K; Hamada T; Osako M; Takao S; Batra SK; Aikou T; Imai K; Yonezawa S
    J Clin Pathol; 2005 Aug; 58(8):845-52. PubMed ID: 16049287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucins secreted by cell lines derived from colorectal mucinous carcinoma and adenocarcinoma.
    Cho M; Dahiya R; Choi SR; Siddiki B; Yeh MM; Sleisenger MH; Kim YS
    Eur J Cancer; 1997 May; 33(6):931-41. PubMed ID: 9291818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pancreatic cancer microenvironment].
    Dąbkowski K; Bogacka B; Tarnowski M; Starzyńska T
    Pol Merkur Lekarski; 2016 Dec; 41(246):296-302. PubMed ID: 28024135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy.
    Nakamura A; Horinouchi M; Goto M; Nagata K; Sakoda K; Takao S; Imai K; Kim YS; Sato E; Yonezawa S
    J Pathol; 2002 Jun; 197(2):201-10. PubMed ID: 12015744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucin in cancer: a stealth cloak for cancer cells.
    Wi DH; Cha JH; Jung YS
    BMB Rep; 2021 Jul; 54(7):344-355. PubMed ID: 34154702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy.
    Singh AP; Chaturvedi P; Batra SK
    Cancer Res; 2007 Jan; 67(2):433-6. PubMed ID: 17234748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic Stellate Cells: The Key Orchestrator of The Pancreatic Tumor Microenvironment.
    Thomas D; Radhakrishnan P
    Adv Exp Med Biol; 2020; 1234():57-70. PubMed ID: 32040855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting hypoxic tumor microenvironment in pancreatic cancer.
    Tao J; Yang G; Zhou W; Qiu J; Chen G; Luo W; Zhao F; You L; Zheng L; Zhang T; Zhao Y
    J Hematol Oncol; 2021 Jan; 14(1):14. PubMed ID: 33436044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The membrane-bound mucins: From cell signalling to transcriptional regulation and expression in epithelial cancers.
    Jonckheere N; Van Seuningen I
    Biochimie; 2010 Jan; 92(1):1-11. PubMed ID: 19818375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the tumor microenvironment in the progression of pancreatic cancer.
    Farrow B; Albo D; Berger DH
    J Surg Res; 2008 Oct; 149(2):319-28. PubMed ID: 18639248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma.
    Tang D; Wang D; Yuan Z; Xue X; Zhang Y; An Y; Chen J; Tu M; Lu Z; Wei J; Jiang K; Miao Y
    Int J Cancer; 2013 Mar; 132(5):993-1003. PubMed ID: 22777597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic stellate cells: Aiding and abetting pancreatic cancer progression.
    Pothula SP; Pirola RC; Wilson JS; Apte MV
    Pancreatology; 2020 Apr; 20(3):409-418. PubMed ID: 31928917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.
    Andrianifahanana M; Moniaux N; Schmied BM; Ringel J; Friess H; Hollingsworth MA; Büchler MW; Aubert JP; Batra SK
    Clin Cancer Res; 2001 Dec; 7(12):4033-40. PubMed ID: 11751498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophil-Derived Proteases in the Microenvironment of Pancreatic Cancer -Active Players in Tumor Progression.
    Felix K; Gaida MM
    Int J Biol Sci; 2016; 12(3):302-13. PubMed ID: 26929737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metastasis-associated fibroblasts promote angiogenesis in metastasized pancreatic cancer via the CXCL8 and the CCL2 axes.
    Pausch TM; Aue E; Wirsik NM; Freire Valls A; Shen Y; Radhakrishnan P; Hackert T; Schneider M; Schmidt T
    Sci Rep; 2020 Mar; 10(1):5420. PubMed ID: 32214219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
    Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
    J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis and differential diagnosis of intraductal papillary mucinous neoplasm of pancreas].
    Ji Y; Tan YS; Zhu XZ; Zeng HY; Kuang TT; Jin DY
    Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):77-81. PubMed ID: 16630480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protease-activated receptor 2 suppresses lymphangiogenesis and subsequent lymph node metastasis in a murine pancreatic cancer model.
    Shi K; Queiroz KC; Roelofs JJ; van Noesel CJ; Richel DJ; Spek CA
    J Pathol; 2014 Nov; 234(3):398-409. PubMed ID: 25065357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycosylation pathways of human corneal and conjunctival epithelial cell mucins.
    Brockhausen I; Elimova E; Woodward AM; Argüeso P
    Carbohydr Res; 2018 Dec; 470():50-56. PubMed ID: 30392563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microenvironmental Determinants of Pancreatic Cancer.
    Hessmann E; Buchholz SM; Demir IE; Singh SK; Gress TM; Ellenrieder V; Neesse A
    Physiol Rev; 2020 Oct; 100(4):1707-1751. PubMed ID: 32297835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.